非瓣膜性心房颤动左心耳血栓形成的原因及危险因素研究进展

doi:10.3969/j.issn.1004-583X.2025.12.013

摘要/Abstract

摘要：

心房颤动（房颤）是最常见的室上性快速性心律失常，血栓栓塞事件作为最常见的并发症，脑卒中以较高的发生率严重影响患者预后，非瓣膜房颤最常见的血栓来源于左心耳，CHA₂DS₂-VASc评分系统虽然作为临床评估血栓栓塞风险的常用方法，但目前研究显示影响左心耳血栓形成的病因复杂，其中危险因素涉及左心耳的结构及功能、临床检验及超声心动图等辅助检查。现对非瓣膜性心房颤动左心耳血栓形成的原因及危险因素研究进展进行综述。

中图分类号:

R541

段兵, 孟瑶, 吴琳, 米杰. 非瓣膜性心房颤动左心耳血栓形成的原因及危险因素研究进展[J]. 临床荟萃, 2025, 40(12): 1124-1129.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.lchc.cn/CN/10.3969/j.issn.1004-583X.2025.12.013

https://www.lchc.cn/CN/Y2025/V40/I12/1124

参考文献 55

[1]	中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6):572-618.
[2]	Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China[J]. J Epidemiol, 2008, 18(5):209-216. doi: 10.2188/jea.je2008021. pmid: 18776706
[3]	刘铎, 李燕玲, 张展, 等. 非瓣膜性心房颤动左心耳血栓的影像学研究进展[J]. 中华老年多器官疾病杂志, 2024, 23(7):545-548.
[4]	郑茜王敏, 冉海涛, 苏蕾. 超声心动图评价心房颤动患者左心耳形态结构和功能的研究进展[J]. 中国医学影像学杂志, 2023, 31(7):795-798.
[5]	Sun Y, Ling Y, Chen Z, et al. Finding low CHA2DS2-VASc scores unreliable? Why not give morphological and hemodynamic methods a try?[J]. Front Cardiovasc Med, 2023, 9:1032736. doi: 10.3389/fcvm.2022.1032736.
[6]	李雯琳, 张志. 心房颤动患者左心耳形态结构和功能与左心耳血栓及心源性卒中的关系研究进展[J]. 临床荟萃, 2024, 39(2):168-171. doi: 10.3969/j.issn.1004-583X.2024.02.014
[7]	Wang Y, Di Biase L, Horton RP, et al. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement[J]. J Cardiovasc Electrophysiol, 2010, 21(9):973-982. doi: 10.1111/j.1540-8167.2010.01814.x.
[8]	Wang F, Zhu M, Wang X, et al. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2018, 18(1):153. doi: 10.1186/s12872-018-0889-y.
[9]	吴金家, 莫善洪. 非瓣膜性心房颤动左心耳血栓形成的研究进展[J]. 基层医学论坛, 2024, 28(1):26-28.doi:10.19435/j.1672-1721.2024.01.008.
[10]	Du H, Bi K, Xu L, et al. Analysis of risk factors for thrombosis of the left atrium/left atrial appendage in patients with non-valvular atrial fibrillation[J]. Cardiovasc J Afr, 2021, 32(3):116-122. doi: 10.5830/CVJA-2019-071.
[11]	侯玲丽, 任建丽. 实时三维经食管超声心动图评估左心耳结构和功能的研究进展[J]. 临床超声医学杂志, 2021, 23(1):57-60.doi:10.16245/j.cnki.issn1008-6978.2021.01.018.
[12]	Wang X, Xu X, Wang W, et al. Risk factors associated with left atrial appendage thrombosis in patients with non-valvular atrial fibrillation by transesophageal echocardiography[J]. Int J Cardiovasc Imaging, 2023, 39(7):1263-1273. doi: 10.1007/s10554-023-02841-x. pmid: 37149503
[13]	Yamamoto T, Endo D, Matsushita S, et al. Evidence and challenges in left atrial appendage management[J]. Ann Thorac Cardiovasc Surg, 2022, 28(1):1-17. doi: 10.5761/atcs.ra.21-00040.
[14]	张磊, 陈琳, 富路. 脑利钠肽在心房颤动中的应用[J]. 心血管康复医学杂志, 2021, 30(6):742-746.
[15]	Inohara T, Kim S, Pieper K, et al. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation[J]. Heart, 2019, 105(5):370-377. doi: 10.1136/heartjnl-2018-313642. pmid: 30228248
[16]	杜鑫, 薛禹辰, 杨清. 超声心动图在心房颤动诊疗中的应用进展[J]. 中国医药, 2019, 14(9):1430-1433.
[17]	Wang G, Li G, Hu F, et al. Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA2DS2-VASc score in patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2023, 23(1):180. doi: 10.1186/s12872-022-03033-6.
[18]	Qiao Y, Zhao Z, Cai X, et al. Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk[J]. Thromb J, 2023, 21(1):34. doi: 10.1186/s12959-023-00478-3. pmid: 36998006
[19]	Kamili K, Zheng T, Luo C, et al. Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: A cross-sectional study[J]. Lipids Health Dis, 2024, 23(1):22. doi: 10.1186/s12944-023-01990-1.
[20]	Zhang Y, Yuan YQ. Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation[J]. Arq Bras Cardiol, 2021, 116(2):325-331. English, Portuguese. doi: 10.36660/abc.20190492. pmid: 33470330
[21]	Wai SH, Kyu K, Galupo MJ, et al. Assessment of left atrial appendage function by transthoracic pulsed Doppler echocardiography: Comparing against transesophageal interrogation and predicting echocardiographic risk factors for stroke[J]. Echocardiography, 2017, 34(10):1478-1485. doi: 10.1111/echo.13659. pmid: 28849595
[22]	Doukky R, Garcia-Sayan E, Gage H, et al. The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation[J]. Cardiovasc Ultrasound, 2014, 12:10. doi: 10.1186/1476-7120-12-10.
[23]	Uziębło-życzkowska B, Krzesiński P, Jurek A, et al. Left Ventricular ejection fraction is associated with the risk of thrombus in the left atrial appendage in patients with atrial fibrillation[J]. Cardiovasc Ther, 2020, 2020:3501749. doi: 10.1155/2020/3501749.
[24]	Wybraniec MT, Mizia-Szubryt M, Cichoń M, et al. Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter[J]. ESC Heart Fail, 2022, 9(6):4064-4076. doi: 10.1002/ehf2.14105. pmid: 36039813
[25]	Kaufmann D, Wabich E, Kapłon-Cie'slicka A, et al. Echocardiographic predictors of thrombus in left atrial appendage-The role of novel transthoracic parameters[J]. Front Cardiovasc Med, 2022, 9:1059111. doi: 10.3389/fcvm.2022.1059111.
[26]	Deng B, Nie R, Qiu Q, et al. 3D transesophageal echocardiography assists in evaluating the morphology, function, and presence of thrombi of left atrial appendage in patients with atrial fibrillation[J]. Ann Transl Med, 2021, 9(10):876. doi: 10.21037/atm-21-1981. pmid: 34164510
[27]	Chen L, Xu C, Chen W, et al. Left atrial appendage orifice area and morphology is closely associated with flow velocity in patients with nonvalvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2021, 21(1):442. doi: 10.1186/s12872-021-02242-9.
[28]	郭楚娴, 杨龙, 张敏, 等. 左心耳血流速度对非瓣膜性心房颤动患者左心耳血栓形成的预测价值评估[J]. 中国循环杂志, 2022, 37(8):831-835.
[29]	Chen L, Zinda A, Rossi N, et al. A new risk model of assessing left atrial appendage thrombus in patients with atrial fibrillation - Using multiple clinical and transesophageal echocardiography parameters[J]. Int J Cardiol, 2020, 314:60-63. doi: 10.1016/j.ijcard.2020.04.039. pmid: 32305560
[30]	Yosefy C, Pery M, Nevzorov R, et al. Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation[J]. Clin Cardiol, 2020, 43(1):71-77. doi: 10.1002/clc.23292. pmid: 31755572
[31]	He Y, Chen P, Zhu Z, et al. Left atrial appendage depth and tachycardia bradycardia syndrome as important predictors of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation[J]. Comput Math Methods Med, 2022, 2022:4632823. doi: 10.1155/2022/4632823.
[32]	Castellani C, Gao Y, Kim H, et al. Left atrial appendage structural characteristics predict thrombus formation[J]. J Cardiovasc Electrophysiol, 2023, 34(8):1683-1689. doi: 10.1111/jce.15994.
[33]	黄晓华, 陈玉香, 谢超贤, 等. CTA定量评价广西壮族人群非瓣膜性房颤患者左心耳结构与血栓形成关联性及意义[J]. 中国CT和MRI杂志, 2023, 21(8):75-78.
[34]	Mill J, Harrison J, Saiz-Vivo M, et al. The role of the pulmonary veins on left atrial flow patterns and thrombus formation[J]. Sci Rep, 2024, 14(1):5860. doi: 10.1038/s41598-024-56658-2. pmid: 38467726
[35]	Fang R, Li Y, Zhang Y, et al. Impact of left atrial appendage location on risk of thrombus formation in patients with atrial fibrillation[J]. Biomech Model Mechanobiol, 2021, 20(4):1431-1443. doi: 10.1007/s10237-021-01454-4.
[36]	Nako S, Seo C, Tsutsui S, et al. Predicting intracardiac thrombus formation in the left atrial appendage using machine learning and CT images[J]. Annu Int Conf IEEE Eng Med Biol Soc, 2023, 2023:1-5. doi: 10.1109/EMBC40787.2023.10340345. pmid: 38082730
[37]	Jing M, Xi H, Li J, et al. Left atrial appendage thrombus is associated with a higher fractal dimension in patients with atrial fibrillation[J]. Clin Imaging, 2024, 114:110247. doi: 10.1016/j.clinimag.2024.110247.
[38]	Alinezhad L, Ghalichi F, Ahmadlouydarab M, et al. Left atrial appendage shape impacts on the left atrial flow hemodynamics: A numerical hypothesis generating study on two cases[J]. Comput Methods Programs Biomed, 2022, 213:106506. doi: 10.1016/j.cmpb.2021.106506.
[39]	Zhou X, Wang Z, Dou S, et al. Biomarkers for predicting left atrial or left atrial appendage thrombus in anticoagulated patients with nonvalvular atrial fibrillation[J]. Cardiol Res Pract, 2020, 2020:1683142. doi: 10.1155/2020/1683142.
[40]	Sun S, Su B, Lin J, et al. A nomogram to predict left atrial appendage thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients[J]. BMC Cardiovasc Disord, 2022, 22(1):311. doi: 10.1186/s12872-022-02737-z.
[41]	Akamatsu K, Ito T, Ozeki M, et al. Left atrial spontaneous echo contrast occurring in patients with low CHADS2 or CHA2DS2-VASc scores[J]. Cardiovasc Ultrasound, 2020, 18(1):31. doi: 10.1186/s12947-020-00213-2.
[42]	Harada M, Tabako S, Fujii Y, et al. Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function[J]. J Echocardiogr, 2018, 16(2):72-80. doi: 10.1007/s12574-017-0362-4. pmid: 29256043
[43]	Hautmann M, Zacher M, Fuchs S, et al. Left atrial appendage thrombus formation, potential of resolution and association with prognosis in a large real-world cohort[J]. Sci Rep, 2023, 13(1):889. doi: 10.1038/s41598-023-27622-3. pmid: 36650206
[44]	Lim HS, Willoughby SR, Schultz C, et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: Impact of rate and rhythm[J]. J Am Coll Cardiol, 2013, 61(8):852-860. doi: 10.1016/j.jacc.2012.11.046. pmid: 23333141
[45]	Deng Y, Zhou F, Li Q, et al. Associations between neutrophil-lymphocyte ratio and monocyte to high-density lipoprotein ratio with left atrial spontaneous echo contrast or thrombus in patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord, 2023, 23(1):234. doi: 10.1186/s12872-023-03270-3.
[46]	何长健, 张艳, 马建帅, 等. 中性粒细胞/淋巴细胞比值与非瓣膜性心房颤动患者左心耳血栓状态的相关性[J]. 中国循环杂志, 2021, 36(9):891-896.
[47]	Koca F, Levent F, Sensoy B, et al. The predictive value of the systemic immune-inflammatory index for left atrial appendage thrombus in non-valvular atrial fibrillation[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2023, 167(2):162-168. doi: 10.5507/bp.2023.007. pmid: 36756877
[48]	Yao Y, Shang MS, Gao LJ, et al. Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score[J]. Europace, 2018, 20(7):1093-1098. doi: 10.1093/europace/eux189. pmid: 28637244
[49]	薛倩, 卓小桢, 杨春, 等. 基于列线图构建非瓣膜性房颤患者的左心耳血栓状态预测模型[J]. 分子影像学杂志, 2021, 44(2):232-238.
[50]	Goel R, Josephson CD, Patel EU, et al. Perioperative transfusions and venous thromboembolism[J]. Pediatrics, 2020, 145(4):e20192351. doi: 10.1542/peds.2019-2351.
[51]	赵曌, 王文强, 赵春慧, 等. 血小板形态参数、左心耳血流动力学参数与老年非瓣膜性心房颤动患者左心耳血栓形成的关系研究[J]. 实用心脑肺血管病杂志, 2022, 30(3):22-27.
[52]	Song J, Zhang X, Wei M, et al. Association between lipoprotein(a) and thromboembolism in patients with non-valvular atrial fibrillation: A cross-sectional study[J]. Lipids Health Dis, 2022, 21(1):78. doi: 10.1186/s12944-022-01682-2. pmid: 36002888
[53]	Meng W, Wang L, Fan H, et al. Total bilirubin level is associated with the risk of left atrial appendage thrombosis in patients with non-valvular atrial fibrillation[J]. Glob Heart, 2022, 17(1):90. doi: 10.5334/gh.1177. pmid: 36578911
[54]	Kapłon-Cie'slicka A, Budnik M, Gawałko M, et al. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus[J]. Heart, 2019, 105(17):1310-1315. doi: 10.1136/heartjnl-2018-314492. pmid: 31040170
[55]	Wang A, Green JB, Halperin JL, et al. Atrial fibrillation and diabetes mellitus: JACC review topic of the week[J]. J Am Coll Cardiol, 2019, 74(8):1107-1115. doi: 10.1016/j.jacc.2019.07.020. pmid: 31439220

非瓣膜性心房颤动左心耳血栓形成的原因及危险因素研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 55

相关文章 15

编辑推荐

Metrics

本文评价

[1]	司会莉, 郭爽, 董浩铖, 李树仁. JP2与原发性高血压患者心房颤动的相关性[J]. 临床荟萃, 2025, 40(6): 504-508.
[2]	刘佳, 杨丰宇, 郭梦雅, 吴卓威, 张瀚文, 王译萱, 陈春红, 张芳. 低剂量利伐沙班用于肾功能不全的高龄心房颤动患者的安全性和有效性[J]. 临床荟萃, 2025, 40(6): 509-512.
[3]	马亚敏, 耿涛. 沙库巴曲缬沙坦在心房颤动中的研究现状[J]. 临床荟萃, 2025, 40(5): 463-467.
[4]	田晓婷, 卢泽芬. 肺癌患者静脉血栓栓塞危险因素的研究进展[J]. 临床荟萃, 2025, 40(5): 473-476.
[5]	苏芮, 王存凯, 王鼎鑫, 蔡聪会, 张建, 侯洪涛, 白云. 肝硬化患者抗凝治疗有效性和安全性的meta分析[J]. 临床荟萃, 2025, 40(4): 293-303.
[6]	刘金华, 王春梅, 王莹, 陈凯. 老年营养风险指数对老年急性脑梗死患者静脉溶栓短期转归的预测价值[J]. 临床荟萃, 2025, 40(1): 21-28.
[7]	朱萌然, 胡宵月, 苏芮, 杨旭旭, 漆平, 白云. 肝硬化凝血功能紊乱与出血、血栓形成的研究进展[J]. 临床荟萃, 2024, 39(7): 658-663.
[8]	于菁怡, 司元国, 兰翠霞, 邢家璇. 新冠肺炎患者院外使用利伐沙班抗凝安全性和有效性的meta分析[J]. 临床荟萃, 2024, 39(6): 485-493.
[9]	王娇燕, 严超, 应可净. 气道慢性炎症性疾病并发静脉血栓栓塞症的研究进展[J]. 临床荟萃, 2024, 39(5): 470-474.
[10]	陈诗雨, 罗专波. 肿瘤相关静脉血栓栓塞症研究进展[J]. 临床荟萃, 2024, 39(4): 363-369.
[11]	陈岚, 李叶琼, 冶秀鹏. 费城染色体阴性骨髓增殖性肿瘤患者血栓形成影响因素[J]. 临床荟萃, 2024, 39(4): 370-375.
[12]	王奕涵, 秦旭雁, 韩宣泽, 王樱洁, 高菲菲, 陈春红, 张岭楠, 张芳. 利伐沙班用于HASBLED评分≥3分的高龄非瓣膜性心房颤动患者的有效性和安全性[J]. 临床荟萃, 2024, 39(2): 121-124.
[13]	李雯琳, 张志. 心房颤动患者左心耳形态结构和功能与左心耳血栓及心源性卒中的关系研究进展[J]. 临床荟萃, 2024, 39(2): 168-171.
[14]	朱春瑜, 林春艺, 翁兰, 杨洵杰, 董帝辉. 高功率短时程在持续性心房颤动改良BOXI术式中的有效性和安全性[J]. 临床荟萃, 2024, 39(10): 915-920.
[15]	彭伊梦, 姚杨, 李思雨, 丁格, 孙亚楠, 王胜昱. 体外膜肺氧合并发血栓发生率的meta分析[J]. 临床荟萃, 2024, 39(1): 5-11.